| 1 | 1322429 | Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro. | J Clin Endocrinol Metab | 1992 Aug |
5 |
| 2 | 2297461 | Effect of increasing oral doses of loperamide on gallbladder motility in man. | Br J Clin Pharmacol | 1990 Jan |
1 |
| 3 | 2545766 | Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism. | J Endocrinol Invest | 1989 Jan |
4 |
| 4 | 2820051 | Loperamide--an opiate receptor agonist with gastrointestinal motility effects. | Scand J Gastroenterol Suppl | 1987 |
1 |
| 5 | 2832297 | Loperamide modifies but does not block the corticotropin-releasing hormone-induced ACTH response in patients with Addison's disease. | Horm Metab Res Suppl | 1987 |
5 |
| 6 | 2836258 | Calmodulin-mediated effects of loperamide on chloride transport by brush border membrane vesicles from human ileum. | Gastroenterology | 1988 Jul |
7 |
| 7 | 2855105 | Loperamide, an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease. | Neuroendocrinology | 1988 Dec |
17 |
| 8 | 2901674 | Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice. | Neuropharmacology | 1988 Apr |
2 |
| 9 | 2979685 | Effect of two potent calmodulin antagonists on calcium transport of brush border and basolateral vesicles from human duodenum. | Aliment Pharmacol Ther | 1987 Oct |
2 |
| 10 | 3024866 | Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease. | Clin Endocrinol (Oxf) | 1986 May |
4 |
| 11 | 6319884 | Loperamide: evidence of interaction with mu and delta opioid receptors. | Life Sci | 1983 |
1 |
| 12 | 6382576 | Mechanisms of action of loperamide. | Scand J Gastroenterol Suppl | 1984 |
1 |
| 13 | 7544198 | The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor. | Br J Pharmacol | 1995 May |
1 |
| 14 | 7699214 | Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions. | J Endocrinol Invest | 1994 Nov |
1 |
| 15 | 8090278 | In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide. | Neuroendocrinology | 1994 Jul |
6 |
| 16 | 8232760 | Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro. | Neuroendocrinology | 1993 Jun |
2 |
| 17 | 8508715 | Loperamide. Survey of studies on mechanism of its antidiarrheal activity. | Dig Dis Sci | 1993 Jun |
1 |
| 18 | 8574143 | Calmodulin inhibitors and calcium channel blockers influence dideoxycytidine renal excretion. | Cell Mol Biol (Noisy-le-grand) | 1995 |
2 |
| 19 | 8647944 | P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. | J Clin Invest | 1996 Jun 1 |
4 |
| 20 | 8877029 | Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man. | Br J Clin Pharmacol | 1996 Sep |
6 |
| 21 | 9575405 | [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles]. | Eksp Klin Farmakol | 1998 Jan-Feb |
2 |
| 22 | 10717506 | An overview of clinical studies with racecadotril in adults. | Int J Antimicrob Agents | 2000 Feb |
1 |
| 23 | 10718373 | Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. | Shock | 2000 Mar |
2 |
| 24 | 10742982 | Multidrug-resistance transporters. | Pharm Biotechnol | 1999 |
1 |
| 25 | 10766372 | Determination of loperamide in rat plasma and bovine serum albumin by LC. | J Pharm Biomed Anal | 2000 Apr |
1 |
| 26 | 10875545 | Effect of loperamide on Na+/D-glucose cotransporter activity in mouse small intestine. | J Pharm Pharmacol | 2000 Jun |
3 |
| 27 | 11474216 | Effects of loperamide and other opioid-related substances on the transcriptional regulation of the rat pro-opiomelanocortin gene in AtT20 cells. | Neuroendocrinology | 2001 Aug |
3 |
| 28 | 11939306 | Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States. | Am J Vet Res | 2002 Apr |
1 |
| 29 | 11964599 | Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. | Anesthesiology | 2002 Apr |
4 |
| 30 | 12164380 | Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. | J Drug Target | 2002 Jun |
2 |
| 31 | 12948013 | Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro. | Pharm Res | 2003 Aug |
1 |
| 32 | 14516411 | Loperamide increases glucose ultilization in streptozotocin-induced diabetic rats. | Clin Exp Pharmacol Physiol | 2003 Oct |
4 |
| 33 | 14583678 | Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers. | Pharmacogenetics | 2003 Nov |
5 |
| 34 | 14586389 | No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects. | Clin Pharmacol Ther | 2003 Nov |
1 |
| 35 | 14613723 | Potential roles of P-gp and calcium channels in loperamide and diphenoxylate transport. | Toxicol Appl Pharmacol | 2003 Nov 15 |
1 |
| 36 | 14765742 | Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. | J Vet Intern Med | 2004 Jan-Feb |
1 |
| 37 | 15244080 | pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study. | Drug Dev Ind Pharm | 2004 May |
7 |
| 38 | 15501934 | The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. | Biophys J | 2005 Jan |
4 |
| 39 | 15553234 | Use of loperamide as a phenotypic probe of mdr1a status in CF-1 mice. | Pharm Res | 2004 Oct |
1 |
| 40 | 15687373 | Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. | J Pharmacol Exp Ther | 2005 Jun |
2 |
| 41 | 15835747 | Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects. | Pharm Res | 2005 Mar |
4 |
| 42 | 15942125 | Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa. | J Pharmacol Sci | 2005 Jun |
2 |
| 43 | 15959754 | Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells. | Diabetologia | 2005 Jul |
2 |
| 44 | 16185316 | mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man. | Neurogastroenterol Motil | 2005 Oct |
8 |
| 45 | 16406665 | Effect of opioid mu-receptors activation on insulin signals damaged by tumor necrosis factor alpha in myoblast C2C12 cells. | Neurosci Lett | 2006 Apr 24 |
2 |
| 46 | 16537797 | Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier. | J Pharmacol Exp Ther | 2006 Jun |
1 |
| 47 | 16554356 | Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. | J Pharmacol Exp Ther | 2006 Jun |
1 |
| 48 | 17664252 | Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. | Drug Metab Dispos | 2007 Nov |
1 |
| 49 | 17683917 | A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. | Eur Neuropsychopharmacol | 2008 Mar |
1 |
| 50 | 17889094 | Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture. | Toxicol Appl Pharmacol | 2007 Dec 1 |
1 |